<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03114059</url>
  </required_header>
  <id_info>
    <org_study_id>STI 06/16</org_study_id>
    <nct_id>NCT03114059</nct_id>
  </id_info>
  <brief_title>5 Years Long Term Results After Standalone CyPass-Implantation</brief_title>
  <official_title>Retro- and Prospective Monocentric Study to Evaluate the Safety and Effectiveness of the CyPass Stent 5 Years After Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dietrich-Bonhoeffer-Klinikum</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dietrich-Bonhoeffer-Klinikum</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the results of all clinically relevant findings of glaucoma diagnostics
      5 Years after stent-implantation concerning the safety and effectiveness of the cypass stent
      procedure. The comparison of Preoperative and long term postoperative results is the aim of
      this study to evaluate this young procedure of Glaucoma surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a post market study without interventions.The participants have been treated with
      CyPass-Stent implantation between 3 and 7 years ago to control the intraocular pressure .
      They will be invited for only one follow up visit to determine the present glaucoma status
      again, to determine the long term safety and effectiveness of the cypass stent procedure and
      to see whether addition therapy or surgical intervention is necessary.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Target Pressure</measure>
    <time_frame>up to 7 years</time_frame>
    <description>The Measurement of the intraocular Pressure is a criteria for the Efficacy of CyPass Stent Procedure (success rate). The postoperative target pressure of 15 mmHg, 18 mmHg or 21 mmHg (depends on Glaucoma Status) has to be achieved.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pressure Change vs Baseline</measure>
    <time_frame>up to 7 years</time_frame>
    <description>The Measurement of the intraocular Pressure change is a criteria for the Efficacy of CyPass Stent Procedure (success rate). The postoperative pressure has to be compared with the baseline pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of additional Medication</measure>
    <time_frame>up to 7 years</time_frame>
    <description>The number of additional Glaucoma medication is another criteria to determine the Efficacy of CyPass Stent Procedure (success rate).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Secondary glaucoma procedures</measure>
    <time_frame>up to 7 years</time_frame>
    <description>To determine the Efficacy of CyPass Stent Procedure completely the number of secondary glaucoma interventions (Surgery/ Laser) has to be documented</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stability of optic nerve</measure>
    <time_frame>up to 7 years</time_frame>
    <description>The Measurement of the optic nerve (HRT) in comparison to the baseline is needed to evaluate the glaucoma damage and to determine the Longterm success rate and the safety of the CyPass- Stent-Procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stability of the Retinal Nerve Fiber Layer Thickness</measure>
    <time_frame>up to 7 years</time_frame>
    <description>The comparison of the preoperative and postoperative Status of the Retinal Nerve Fiber Layer Thickness is another criteria to determine the absolute and relative success</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stability of Visual Field</measure>
    <time_frame>up to 7 years</time_frame>
    <description>The parameter of the Visual Field (Mean Deviation) will be measured to evaluate the Safety of the CyPass-Procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stability of Stent Position</measure>
    <time_frame>up to 7 years</time_frame>
    <description>Determination of Stent Position in the angle will be performed to exclude moving of the Stent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stability of Stent tissue interaction</measure>
    <time_frame>up to 7 years</time_frame>
    <description>Determination of Iris tissue reaction to the Stent will be performed. We document slight reaction without involving the opening, Iris reaction with involving the opening and complete closure by Tissue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-and postoperative complications</measure>
    <time_frame>up to 7 years</time_frame>
    <description>The number of Intra-and postoperative complications are needed to evaluate the Safety of the CyPass-Procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suprachoroidal Bleb</measure>
    <time_frame>up to 7 years</time_frame>
    <description>The Determination of the Suprachoroidal Bleb is needed to evaluate the function of the Stent and the Efficacy of the procedure</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>standalone CyPass implantation</arm_group_label>
    <description>patients who have undergone a standalone cypass implantation without cataract surgery more than 3 years ago</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Glaucoma diagnostics</intervention_name>
    <description>Heidelberg, Retinal Topography, Visual field, intraocular pressure, medication anamnesis, Retinal Nerve Fibre Layer Thickness, Pachymetry, Sonography, full ophthalmological determination</description>
    <arm_group_label>standalone CyPass implantation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        130 Patient with at least one treated eye
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who have undergone a standalone cypass implantation at least 3 years ago

          -  signed inform consent

        Exclusion Criteria:

          -  Patients with to much travel distance between study center and home

          -  Patients who cannot visit the studycenter due to health problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helmut Hoeh, MD,FEBO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, Neubrandenburg, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dietrich-Bonhoeffer-Klinikum</name>
      <address>
        <city>Neubrandenburg</city>
        <state>Mecklenburg/Vorpommern</state>
        <zip>17036</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Hoeh H, Vold SD, Ahmed IK, Anton A, Rau M, Singh K, Chang DF, Shingleton BJ, Ianchulev T. Initial Clinical Experience With the CyPass Micro-Stent: Safety and Surgical Outcomes of a Novel Supraciliary Microstent. J Glaucoma. 2016 Jan;25(1):106-12. doi: 10.1097/IJG.0000000000000134.</citation>
    <PMID>25304276</PMID>
  </results_reference>
  <results_reference>
    <citation>García-Feijoo J, Rau M, Grisanti S, Grisanti S, Höh H, Erb C, Guguchkova P, Ahmed I, Grabner G, Reitsamer H, Shaarawy T, Ianchulev T. Supraciliary Micro-stent Implantation for Open-Angle Glaucoma Failing Topical Therapy: 1-Year Results of a Multicenter Study. Am J Ophthalmol. 2015 Jun;159(6):1075-1081.e1. doi: 10.1016/j.ajo.2015.02.018. Epub 2015 Mar 3.</citation>
    <PMID>25747677</PMID>
  </results_reference>
  <results_reference>
    <citation>Grisanti S, Margolina E, Hoeh H, Rau M, Erb C, Kersten-Gomez I, Dick HB, Grisanti S. [Supraciliary microstent for open-angle glaucoma: clinical results of a prospective multicenter study]. Ophthalmologe. 2014 Jun;111(6):548-52. German.</citation>
    <PMID>23958836</PMID>
  </results_reference>
  <results_reference>
    <citation>Höh H, Grisanti S, Grisanti S, Rau M, Ianchulev S. Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monbl Augenheilkd. 2014 Apr;231(4):377-81. doi: 10.1055/s-0034-1368214. Epub 2014 Apr 25.</citation>
    <PMID>24771171</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2017</study_first_submitted>
  <study_first_submitted_qc>April 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2017</study_first_posted>
  <last_update_submitted>November 30, 2017</last_update_submitted>
  <last_update_submitted_qc>November 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Late Effects of Surgery</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>results will be published in ophthalmological journals</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

